BeiGene
ONC
#728
Rank
ยฃ20.20 B
Marketcap
ยฃ173.72
Share price
1.24%
Change (1 day)
63.73%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company